Aperio Group LLC Has $19.53 Million Stake in Agilent Technologies Inc (A)

Aperio Group LLC grew its holdings in shares of Agilent Technologies Inc (NYSE:A) by 2.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 276,809 shares of the medical research company’s stock after acquiring an additional 6,469 shares during the period. Aperio Group LLC owned about 0.09% of Agilent Technologies worth $19,526,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the company. OppenheimerFunds Inc. raised its stake in shares of Agilent Technologies by 64.0% during the second quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock valued at $472,248,000 after acquiring an additional 2,980,216 shares during the last quarter. American Century Companies Inc. increased its position in shares of Agilent Technologies by 30.3% during the second quarter. American Century Companies Inc. now owns 4,585,162 shares of the medical research company’s stock worth $283,546,000 after buying an additional 1,065,877 shares during the period. Wells Fargo & Company MN increased its position in shares of Agilent Technologies by 6.6% during the second quarter. Wells Fargo & Company MN now owns 2,984,214 shares of the medical research company’s stock worth $184,544,000 after buying an additional 183,728 shares during the period. Schwab Charles Investment Management Inc. increased its position in shares of Agilent Technologies by 3.9% during the second quarter. Schwab Charles Investment Management Inc. now owns 1,329,409 shares of the medical research company’s stock worth $82,211,000 after buying an additional 49,527 shares during the period. Finally, Morgan Stanley increased its position in shares of Agilent Technologies by 67.6% during the second quarter. Morgan Stanley now owns 1,227,627 shares of the medical research company’s stock worth $75,917,000 after buying an additional 495,160 shares during the period.

A opened at $64.28 on Tuesday. Agilent Technologies Inc has a twelve month low of $60.42 and a twelve month high of $75.00. The company has a quick ratio of 3.00, a current ratio of 3.62 and a debt-to-equity ratio of 0.39. The firm has a market cap of $20.55 billion, a PE ratio of 27.24, a PEG ratio of 2.21 and a beta of 1.32.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, August 14th. The medical research company reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.04. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The company had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the prior year, the company posted $0.59 earnings per share. Agilent Technologies’s revenue for the quarter was up 8.0% compared to the same quarter last year. As a group, research analysts anticipate that Agilent Technologies Inc will post 2.71 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 24th. Shareholders of record on Tuesday, October 2nd will be issued a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date is Monday, October 1st. Agilent Technologies’s payout ratio is 25.42%.

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, October 16th. Morgan Stanley increased their price objective on shares of Agilent Technologies from $84.00 to $86.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 10th. ValuEngine upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Thursday, September 13th. Deutsche Bank increased their price objective on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, August 15th. Finally, Goldman Sachs Group reiterated a “buy” rating and set a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research report on Tuesday, September 18th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $77.44.

In other Agilent Technologies news, Director Paul N. Clark sold 2,876 shares of the firm’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $68.60, for a total value of $197,293.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total transaction of $371,295.86. The disclosure for this sale can be found here.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

See Also: Ex-Dividend

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply